{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:45:38Z","timestamp":1791099938773,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ahj.2004.01.012","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T05:21:41Z","timestamp":1081488101000},"page":"593-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines"],"prefix":"10.1016","volume":"147","author":[{"given":"John B","family":"Robbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Horwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Naso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fattom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.01.012_BIB1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/infdis\/132.3.316","article-title":"Bacteremia at Boston City Hospital; occurrence and mortality during 12 selected years (1935\u20131972), with special reference to hospital-acquired cases","volume":"132","author":"McGowan","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1047-2797(00)00184-8","article-title":"The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991\u201398","volume":"11","author":"Baine","year":"2001","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/647751","article-title":"Prevalence of nosocomial infections in General Hospitals in Belo Horizonte","volume":"19","author":"Rezende","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.012_BIB5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid0501.990102","article-title":"The economic impact of Staphylococcus aureus infection in New York City Hospitals","volume":"5","author":"Rubin","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB6","first-page":"95","article-title":"Bacteremia in patients on chronic hemodialysis","volume":"65","author":"Kessler","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.ahj.2004.01.012_BIB7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/jb.131.1.194-200.1977","article-title":"Structural analysis of the surface polysaccharide of Staphylococcus aureus","volume":"131","author":"Liau","year":"1977","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/infdis\/140.4.605","article-title":"An electron microscopic India ink technique for demonstrating capsules on microorganisms","volume":"140","author":"Melly","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/iai.19.3.943-949.1978","article-title":"Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes","volume":"l19","author":"Peterson","year":"1978","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM198405243102107","article-title":"Staphylococcus aureus","volume":"310","author":"Sheagren","year":"1984","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2004.01.012_BIB11","unstructured":"Morse SI. Pathogenesis of staphylococcal infections. 1974. Proceedings of the Symposium on New Approaches for Inducing Natural Immunity to Pyogenic Organisms. US Department HEW, PHS, NIH, DHEW Publication No (NIH) 74-553. p 131\u20135"},{"key":"10.1016\/j.ahj.2004.01.012_BIB12","unstructured":"Karakawa WW, Morse JA. 1974. Characterization of the surface antigens of Staphylococcus aureus. Proceedings of the Symposium on New Approaches for Inducing Natural Immunity to Pyogenic Organisms. US Department HEW, PHS, NIH, DHEW Publication No (NIH) 74-553. p 136\u201340"},{"key":"10.1016\/j.ahj.2004.01.012_BIB13","doi-asserted-by":"crossref","unstructured":"de Sousa MA, Maragaia M, Sanches IS, et al. Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol 2001;2197\u2013205","DOI":"10.1128\/JCM.39.6.2197-2205.2001"},{"key":"10.1016\/j.ahj.2004.01.012_BIB14","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/JCM.39.10.3727-3732.2001","article-title":"Epidemiology and susceptibility of 3051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SNTRY study","volume":"39","author":"Fluit","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","article-title":"Whole genome sequence of meticillin-resistant Staphylococcus aureus","volume":"357","author":"Kuroda","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.01.012_BIB16","first-page":"285","article-title":"Capsular polysaccharides of Staphylococcus aureus","volume":"4","author":"Karakawa","year":"1982","journal-title":"Semin Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/jcm.22.3.445-447.1985","article-title":"Methods for the serological typing of the capsular polysaccharides of Staphylococcus aureus","volume":"22","author":"Karakawa","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0732-8893(84)90002-6","article-title":"Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus","volume":"2","author":"Arbeit","year":"1984","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/jcm.22.5.828-834.1985","article-title":"Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types","volume":"22","author":"Sompolinsky","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB20","doi-asserted-by":"crossref","unstructured":"Light IJ, Atherton HD, Sutherland JM. Decreased colonization of newborn infants with Staphylococcus aureus 80\/81: Cincinnati General Hospital, 1960\u20131972. J Infect Dis 131:281\u20135","DOI":"10.1093\/infdis\/131.3.281"},{"key":"10.1016\/j.ahj.2004.01.012_BIB21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/aem.39.3.623-629.1980","article-title":"Computer analysis of Staphylococcus aureus phage-typing data from 1957 to 1975 citing epidemiological trends and natural evaluation with the phage typing system","volume":"39","author":"Zierdt","year":"1980","journal-title":"J Appl Environ Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/iai.56.5.1090-1095.1988","article-title":"Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus hy human polymorphonuclear leukocytes","volume":"56","author":"Karakawa","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB23","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1128\/IAI.69.11.6796-6803.2001","article-title":"Capsule production and growth phase influence binding of complement to Staphylococcus aureus","volume":"69","author":"Cunnion","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB24","doi-asserted-by":"crossref","unstructured":"Brown EJ, Berger M, Joiner KA, et al. Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules. Infect Immun 1983;42:594\u22128","DOI":"10.1128\/iai.42.2.594-598.1983"},{"key":"10.1016\/j.ahj.2004.01.012_BIB25","doi-asserted-by":"crossref","unstructured":"Robbins JB, Schneerson R, Vann WF, et al. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. In: Williams JC, Goldenthal KL, Burns DL, Lewis BP Jr, editors. Combined vaccines and simultaneous administration: current issues and perspectives. N Y Acad Sci 1995;754:68\u201382","DOI":"10.1111\/j.1749-6632.1995.tb44439.x"},{"key":"10.1016\/j.ahj.2004.01.012_BIB26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/infdis\/156.6.947","article-title":"Expression of capsular polysaccharide during experimental focal infection with Staphylococus aureus","volume":"156","author":"Arbeit","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/jcm.27.5.989-993.1989","article-title":"Direct testing of blood cultures for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus","volume":"27","author":"Boutonnier","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/iai.45.1.87-93.1984","article-title":"Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide","volume":"45","author":"Fournier","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0008-6215(90)84244-O","article-title":"The structure of the type 5 capsular polysaccharide of Staphylococcus aureus","volume":"201","author":"Moreau","year":"1990","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.ahj.2004.01.012_BIB30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1965.tb11628.x","article-title":"Speculation on the immunology of Mudd, S. Capsulation, pseudocapsulation, and the somatic antigens of the surface of Staphylococcus aureus","volume":"128","author":"Rogers","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ahj.2004.01.012_BIB31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/jcm.25.3.526-530.1987","article-title":"Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8","volume":"25","author":"Hochkeppel","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB32","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1128\/jcm.26.12.2505-2509.1988","article-title":"Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis","volume":"26","author":"Albus","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB33","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/iai.58.7.2367-2374.1990","article-title":"Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A","volume":"58","author":"Fattom","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/iai.64.5.1659-1665.1996","article-title":"Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies that protect mice against bacterial challenge","volume":"64","author":"Fattom","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1172\/JCI109300","article-title":"Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudmonas aeruginosa septicemia in man","volume":"63","author":"Pollack","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2004.01.012_BIB36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/iai.61.3.1023-1032.1993","article-title":"Laboratory and clinical evaluation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A","volume":"61","author":"Fattom","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1681\/ASN.V72247","article-title":"Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis","volume":"7","author":"Welch","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2004.01.012_BIB39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000187244","article-title":"Depressed phagocytosis in hemodialysis patients","volume":"63","author":"Dell'Aquila","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.ahj.2004.01.012_BIB40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/iai.60.2.584-589.1992","article-title":"Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio) propionate","volume":"60","author":"Fattom","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB41","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.4049\/jimmunol.147.7.2136","article-title":"Evaluation of monophosphoryl lipid A (MPL) as an adjuvant for human immunization","volume":"147","author":"Schneerson","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.ahj.2004.01.012_BIB42","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/IAI.68.4.2161-2166.2000","article-title":"Clostridium difficile recombinant toxin A repeating unit as a carrier protein for conjugate vaccines","volume":"68","author":"Pavliakova","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ahj.2004.01.012_BIB43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(95)70546-5","article-title":"Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines","volume":"126","author":"Greenberg","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2004.01.012_BIB44","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJM195906252602601","article-title":"The relation between the nasal-staphylococcal-carrier state and the incidence of post-operative complications","volume":"260","author":"Weinstein","year":"1959","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2004.01.012_BIB45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0022-5223(19)41455-4","article-title":"Postoperative chest wound infections in patients requiring coronary bypass","volume":"73","author":"Sutherland","year":"1977","journal-title":"J Thoracic Cardiovascular Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB46","first-page":"483","article-title":"Aortocoronary bypass procedures and sternotomy infections","volume":"23","author":"Austin","year":"1980","journal-title":"Can J Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB47","first-page":"61","article-title":"Failure of cephalosporins to prevent Staphyloccus aureus surgical wound infections","volume":"236","author":"Kernodle","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2004.01.012_BIB48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0003-4975(95)90014-4","article-title":"A fifteen-year wound surveillance study after coronary artery bypass","volume":"56","author":"Slaughter","year":"1993","journal-title":"Ann Thor Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/171.1.216","article-title":"Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery","volume":"171","author":"Kluytmans","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1010-7940(00)00327-4","article-title":"The endogenous pathway is a major route for deep sternal wound infection","volume":"17","author":"Jakob","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/clind\/24.4.669","article-title":"Infective endocarditis","volume":"24","author":"Martin","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1440-1622.2000.01837.x","article-title":"Single- versus multiple-dose antibiotics prophylaxis for cardiac surgery","volume":"70","author":"Bucknell","year":"2000","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1010-7940(00)00327-4","article-title":"The endogenous pathway is a major route for deep sternal wound infection","volume":"17","author":"Jakob","year":"2000","journal-title":"Eur J Cardiothoracic Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/hc3401.095097","article-title":"Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defribillators","volume":"104","author":"Chamis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.01.012_BIB55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5223(19)40967-7","article-title":"Changes in peripheral blood leukocyte counts, lymphocyte subpopulations, and in vitro transformation after heart replacement","volume":"77","author":"Ryh\u00e4nen","year":"1979","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2004.01.012_BIB56","doi-asserted-by":"crossref","unstructured":"MacLeod CM, Hodges RG, M. Heidelberger M, et al. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945;82:445\u201365","DOI":"10.1084\/jem.82.6.445"},{"key":"10.1016\/j.ahj.2004.01.012_BIB57","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus. V. The effect of immunization with meninococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.ahj.2004.01.012_BIB58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0163-4453(81)90934-8","article-title":"Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carriage rates","volume":"3","author":"Sivonen","year":"1981","journal-title":"J Infect"},{"key":"10.1016\/j.ahj.2004.01.012_BIB59","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB60","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2004.01.012_BIB61","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective","volume":"171","author":"Robbins","year":"1994","journal-title":"J Infect Dis"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:04:02Z","timestamp":1757567042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0002870304000298"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.01.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}